medigraphic.com
SPANISH

Revista Cubana de Medicina

ISSN 1561-302X (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2018, Number 3

<< Back Next >>

Rev cubana med 2018; 57 (3)

Body mass index and interleukin 6 in the mortality of chronic heart failure patients

Chao PC, Ortega CH, Gutiérrez RÁR, Casas ME
Full text How to cite this article

Language: Spanish
References: 9
Page: 25-33
PDF size: 413.46 Kb.


Key words:

body mass index, prognostic factor, obesity, overweight.

ABSTRACT

Introduction: Chronic heart failure is one of the leading causes of cardiovascular death worldwide. A paradoxical effect of the corporal weight in the mortality of these patients is considered.
Objective: To evaluate the body mass index (BMI) as a prognostic factor in the mortality of patients with chronic heart failure and the relationship with the blood concentration of interleukin 6.
Methods: A prospective cohort analytical study was conducted in patients with chronic heart failure, from January 2016 to December 2016, and they were followed up for one year. 109 patients formed the sample. Cox regression model was used for statistical analysis and statistical significance was calculated as applicable.
Results: The low weight category showed higher influence on the risk of death, OR 2,943 (CI: 1,378-6,285). The overweight-obesity variable presented OR below 1, as the body mass index increased, the IL6 concentration decreased.
Conclusions: The body mass index allows us to offer prognostic information. The lower blood concentration of interleukin 6 in obese patients with respect to normal weight may be an explanation for the higher survival of these patients.


REFERENCES

  1. Kovell LC, Juraschek SP, Russell SD. Stage a heart failure is not adequately recognized in US adults: analysis of the national health and nutrition examination surveys. Plos One. 2015;10(7):e0132228.

  2. Manzano L, Babalis D, Roughton M, Shibata M, Anker SD, Ghio S, et al. Predictors of clinical outcomes in elderly patients with heart failure. Eur J Heart Fail. 2011;13:528-36. 3. Cuba. Ministerio de Salud Pública. Anuario Estadístico de Salud 2016. La Habana: Dirección nacional de Estadística y Registros Médicos; 2017.

  3. Block JP, Subramanian SV, Christakis NA, O'Malley AJ. Population trends and variation in body mass index from 1971 to 2008 in the Framingham heart study offspring cohort. Plos One. 2013;8(5):e63217.

  4. Nicholson C. Chronic heart failure: pathophysiology, diagnosis and treatment. Nurs Older People. 2014;26:29-38.

  5. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Woo MA, Tillisch JA. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol. 2001;38:789-95.

  6. Haehling S, Horwich T, Fonarow G, Anker S. Tipping the scale: heart failure, body mass index, and prognosis. Circulation. 2007;116:588-90.

  7. Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the vesnarinone trial (VEST). Circulation. 2001;103:2055-9.

  8. Feldman AM, Combes A, Wagner D, Kadakomi T, Kubota T, Li YY, et al. The role of tumor necrosis factor in the pathophysiology of heart failure. J Am Coll Cardiol. 2000;35:537-44.

  9. Zamora E, Díez López C, Lupón J, de Antonio M, Domingo M, Santesmases J, et al. Weight loss in obese patients with heart failure. J Am Heart Assoc. 2016;5(3):e002468.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev cubana med. 2018;57